International Business Machines (IBM) director logs deferred fee share grant
Rhea-AI Filing Summary
International Business Machines Corp. director reports deferred fee shares
A director of International Business Machines Corp. reported a compensation-related transaction dated 12/31/2025. The director deferred board fees into 199 "Promised Fee Shares" under the IBM Board of Directors Deferred Compensation and Equity Award Plan, with each derivative security linked to one share of IBM common stock. These promised fee shares have a conversion price of $0.00 and are paid out in IBM common stock or cash after the director retires, with distribution deferred until retirement. Following this transaction, the director beneficially owned 16,835 derivative securities representing deferred fee shares, held directly.
Positive
- None.
Negative
- None.
FAQ
What insider transaction did IBM (IBM) disclose in this filing?
The filing reports that a director deferred board fees into 199 Promised Fee Shares on 12/31/2025 under the IBM Board of Directors Deferred Compensation and Equity Award Plan.
What are IBM Promised Fee Shares mentioned in this insider report?
Promised Fee Shares are derivative securities under IBM's Board of Directors Deferred Compensation and Equity Award Plan that represent deferred director fees, payable in IBM common stock or cash after retirement.
How many IBM shares underlie the director’s new Promised Fee Shares?
The 199 Promised Fee Shares reported each correspond to one share of IBM common stock, for a total underlying amount of 199 shares.
When will the IBM director receive the deferred Promised Fee Shares?
According to the plan terms, the distribution of Promised Fee Shares is deferred until the director’s retirement, at which time they are paid out in IBM common stock or cash.
What is the director’s total IBM deferred fee share balance after this transaction?
After this transaction, the director beneficially owned 16,835 derivative securities representing Promised Fee Shares, held directly.
Is this IBM insider transaction related to compensation or open-market trading?
This transaction reflects a deferral of director fees into Promised Fee Shares under a board compensation plan, rather than an open-market purchase or sale of IBM common stock.